Retrophin $RTRXRetrophin is a small, newly public biotech company in the orphan disease space, led by high-profile young CEO Martin Shkreli.
Website: www.retrophin.com Index of SEC filings under corporate name is Desert Gateway (thanks to the reverse merger transaction that took Retrophin public) RTRX Valuation/Shares/Cash metrics |
|